Catalym

0 followers


Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.

Industries

Headquarters

Stage

Employees

Links

Org chart

Phil L’Huillier
Managing Director & CEO

Phil L’Huillier

Collapse
Christine Schuberth-Wagner
Chief Scientific Officer
Eugen Leo
Chief Medical Officer
Frank Hermann, MD
VP Clinical Development
Jonathan Tobin
Non Executive Director
Marianne Uteng
Board Observer
Petra Fettes
Senior Vice President, Head Clinical Operations
Julia Kruschel
VP Regulatory Affairs